Status:

COMPLETED

Crome/Cobalt Respiration Study

Lead Sponsor:

Medtronic Cardiac Rhythm and Heart Failure

Conditions:

Heart Failure

Eligibility:

All Genders

18+ years

Brief Summary

The goal of this study is to compare measured respiration rates in various subject scenarios and use conditions between capnography and the Crome and Cobalt ICD and CRT-D MRI SureScan devices (derived...

Detailed Description

This study will enroll subjects who have already received a Medtronic Crome or Cobalt ICD or CRT-D MRI SureScan device and who meet all of the inclusion criteria and none of the exclusion criteria. Su...

Eligibility Criteria

Inclusion

  • Subject has an active CromeTM or CobaltTM ICD or CRT-D MRI SureScanTM system which has been implanted for at least 30 days and which has not yet reached the Recommended Replacement Time (RRT)
  • Subject is implanted with one of the following models of a true bipolar right ventricular lead manufactured by Medtronic:
  • Model 6946M
  • Model 6947
  • Model 6947M
  • Model 6935
  • Model 6935M
  • Subject is ≥ 18 years of age
  • Subject (or subject's legally authorized representative) is willing and able to provide written informed consent
  • Subject is willing and able to comply with study procedures

Exclusion

  • Subject has existing condition that necessitates the use of supplemental oxygen
  • Subject has active acute respiratory infection or respiratory disorder that may affect ability to perform breathing or exercise activities, as assessed by the investigator
  • Any concomitant condition that might endanger the subject through participation in the study or interfere with study procedures, as assessed by the investigator
  • Subject has an active or suspected lead integrity issue, in the opinion of the investigator
  • Subject is enrolled in another study that could confound the results of this study
  • Subject has NYHA Class IV heart failure

Key Trial Info

Start Date :

November 21 2023

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 12 2024

Estimated Enrollment :

61 Patients enrolled

Trial Details

Trial ID

NCT06089694

Start Date

November 21 2023

End Date

June 12 2024

Last Update

August 15 2024

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Hartford Hospital

Hartford, Connecticut, United States, 06102

2

CentraCare Heart & Vascular Center

Saint Cloud, Minnesota, United States, 56303-1900

3

South Oklahoma Heart Research

Oklahoma City, Oklahoma, United States, 73135

4

Texas Cardiac Arrhythmia Research Foundation

Austin, Texas, United States, 78705-1852